T. Rowe Price Associates’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-128,228
Closed -$188K 3085
2022
Q2
$188K Sell
128,228
-12,869
-9% -$18.9K ﹤0.01% 2615
2022
Q1
$162K Buy
141,097
+83,839
+146% +$96.3K ﹤0.01% 2750
2021
Q4
$143K Sell
57,258
-36,900
-39% -$92.2K ﹤0.01% 2817
2021
Q3
$482K Sell
94,158
-160,208
-63% -$820K ﹤0.01% 2394
2021
Q2
$2.11M Sell
254,366
-685,865
-73% -$5.7M ﹤0.01% 1713
2021
Q1
$8.19M Sell
940,231
-602,356
-39% -$5.25M ﹤0.01% 1418
2020
Q4
$16.8M Sell
1,542,587
-42,465
-3% -$461K ﹤0.01% 1258
2020
Q3
$18.9M Sell
1,585,052
-442,195
-22% -$5.28M ﹤0.01% 1170
2020
Q2
$32.6M Buy
2,027,247
+645,097
+47% +$10.4M ﹤0.01% 987
2020
Q1
$21.4M Sell
1,382,150
-20,943
-1% -$325K ﹤0.01% 1048
2019
Q4
$34.5M Buy
1,403,093
+1,372,023
+4,416% +$33.8M ﹤0.01% 1028
2019
Q3
$320K Sell
31,070
-604,593
-95% -$6.23M ﹤0.01% 2252
2019
Q2
$7.98M Buy
635,663
+231,109
+57% +$2.9M ﹤0.01% 1347
2019
Q1
$5.01M Buy
+404,554
New +$5.01M ﹤0.01% 1397
2018
Q1
Sell
-359,512
Closed -$4.51M 2573
2017
Q4
$4.51M Buy
359,512
+344,800
+2,344% +$4.33M ﹤0.01% 1428
2017
Q3
$280K Hold
14,712
﹤0.01% 2286
2017
Q2
$222K Sell
14,712
-1,100
-7% -$16.6K ﹤0.01% 2339
2017
Q1
$271K Buy
15,812
+12
+0.1% +$206 ﹤0.01% 2298
2016
Q4
$191K Sell
15,800
-11,100
-41% -$134K ﹤0.01% 2391
2016
Q3
$265K Buy
26,900
+7,500
+39% +$73.9K ﹤0.01% 2262
2016
Q2
$199K Buy
19,400
+7,000
+56% +$71.8K ﹤0.01% 2332
2016
Q1
$150K Hold
12,400
﹤0.01% 2349
2015
Q4
$199K Buy
+12,400
New +$199K ﹤0.01% 2304
2014
Q4
Sell
-585,771
Closed -$15.9M 2571
2014
Q3
$15.9M Buy
585,771
+61,240
+12% +$1.66M ﹤0.01% 1179
2014
Q2
$16.3M Buy
+524,531
New +$16.3M ﹤0.01% 1171